Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter, Pion Pen Distribution Pact for Drug Permeability-analysis Instruments

NEW YORK, Dec. 15 (GenomeWeb News) - Beckman Coulter had entered into a 5-year distribution pact with Pion to deliver instruments for the automation of in vitro drug-permeability instruments.

 

The firms will combine Beckman Coulter's Biomek FX liquid handling system with Pion's double-sink method for parallel artificial membrane permeability analysis. The new instrument, called Biomek FX -ADMETox Workstation, is controlled by software developed by Woburn, Mass.-based Pion.

 

Beckman has validated the automated system and will distribute it worldwide. The firms will collaborate on application-specific customer support and training.

 

Financial terms of the deal were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.